News - Radboudumc

News items related to the Department of Clinical Pharmacy.

The European Hector Research Award in HIV 2021 awarded to Angela Colbers and David Burger

2 November 2021

On Friday 29 October 2021, during the 18th European AIDS Conference in London, the Hector Research Award for the best scientific article related to clinical or epidemiological HIV research was presented to Angela Colbers and David Burger, both working in the Pharmacy of the RadboudUMC.

Rob Aarnoutse is appointed as professor in Translation pharmacology of antimicrobial agents in particular drugs for tuberculosis

25 January 2021

Hospital pharmacist and clinical pharmacologist Rob Aarnoutse is appointed as professor in ‘Translation pharmacology of antimicrobial agents, in particular drugs for tuberculosis’ at Radboud University / Radboudumc, starting 16 November 2020.

The patient's need for medication information and its perceived quality

3 September 2020

In the International Journal of Clinical Pharmacy Charlotte Bekker showed that patients often face unmet medication information needs and that the quality of the provided information, including accessibility, comprehensiveness, reliability and understandability, is perceived as insufficient.

Radboudumc research leads to simplified dose of HIV medication for children

31 August 2020

For children living with HIV, an adapted, simpler combination therapy is now available. Thanks to research by the Radboudumc, it is now clear that the use of one easily available tablet of dolutegravir in children gives just as good treatment results as a combination of several.

650,000 Euro funding for research into the phasing out of medication for leukaemia patients

30 July 2020

With a 650,000 euro funding from ZonMw, researchers from the Haematology and Pharmacy departments can develop a medication phasing out strategy for patients with chronic myeloid leukaemia. This strategy will be tested in practice.

Dolutegravir versus efavirenz in women starting HIV therapy in late pregnancy (DolPHIN-2)

12 May 2020

In Lancet HIV RIHS researchers Angela Colbers and David Burger showed in an open-label, randomized controlled trial, that, when initiated in the 3rd trimester of pregnancy, achievement of VL <50cp/mL at delivery was more likely with dolutegravir-based therapy than with efavirenz-based regimens.

Bart van den Bemt appointed as professor of Personalized Pharmaceutical Care

22 April 2020

Bart van den Bemt will pay particular attention to shared decision-making, improved treatment adherence, effective pharmacotherapy and sustainable drug use.

The effect of pregnancy on the pharmacokinetics of dolutegravir in women living with HIV

17 March 2020

In Clinical infectious diseases RIHS researchers Pauline Bollen, Jolien Freriksen, Angela Colbers and David Burger together with researchers of the PANNA network showed that dolutegravir use in pregnancy results in effective plasma concentrations.

Three Royal decorations for RIHS researchers

29 April 2019

Peter de Smet, Harry Surayapranata and Stans Verhagen received royal honours for their exceptional academic and social achievements.

Dosing anticancer drugs in patients with renal or hepatic impairment

11 April 2019

Renal or hepatic impairment is a common comorbidity for patients with cancer either because of the disease itself, toxicity of previous anticancer treatments, or because of other factors affecting organ function, such as increased age.

Importance of prospective studies in pregnant and breastfeeding women living with HIV

14 March 2019

In Clinical Infectious Diseases Angela Colbers, Stein Schalkwijk and David Burger give considerations on how to effectively evaluate aspects of clinical pharmacology required for safe and effective treatment to optimize pharmacotherapy during pregnancy and breastfeeding.

Beyond the scientist: Roger Brüggemann

13 November 2018

Roger, who subscribed for the national pilot academy in 1992, eventually became a hospital pharmacist and associate professor of clinical pharmacology. This summer he became a “Cinglé du Ventoux”.

Pharmacy receives prestigious European prize for research in Africa

27 September 2018

On 17 September, David Burger, professor of clinical pharmacy, together with colleagues from the United Kingdom, Uganda and Zimbabwe, received the "Outstanding Research Team" award from the European - Developing Countries Clinical Trial Partnership (EDCTP).

Nielka van Erp and Roger Brüggemann appointed associate professor

30 August 2018

It is our pleasure to announce that Nielka van Erp and Roger Brüggemann have been appointed as associated professor.

WHO Toolkit Pregnant and breastfeeding women

8 August 2018

Stein Schalkwijk, Angela Colbers and David Burger (Pharmacy) developed the Toolkit in cooperation with Mark Mirochnick (Boston University) as a part of “Toolkit for research and development of paediatric antiretroviral drugs and formulations”.

The potential for shortening tuberculosis treatment with higher rifampicin doses

5 July 2018

In Clinical Infectious Diseases Elin Svensson and colleagues showed that increasing rifampicin exposure shortened the time needed to reach undetectable levels of bacteria in sputum.

Pharmacokinetics of HIV medicines in pregnant women

28 June 2018

In Clinical Pharmacokinetics David Burger, Ruben van der Galiën and colleagues discuss that although yearly over a million of women with HIV get pregnant, it is often still unknown whether treatment with HIV-integrase inhibitors results in adequate drug exposure.

Reduced-dose efavirenz in HIV-positive pregnant women

14 March 2018

In Clinical Pharmacokinetics Stein Schalkwijk and colleagues described the feasibility to reduce the efavirenz dose in HIV-positive pregnant women to minimize treatment costs and limit toxicity.

Martijn Verbrugge Award for Pauline Bollen

6 February 2018

Pauline received this award for the best abstract of original research on HIV-infected patients. Lecture title: The pharmacokinetics and safety of dolutegravir in HIV-infected pregnant women.

Beyond the scientist: Roeland Wasmann

7 December 2017

Chair of the RIHS PhD council and PhD candidate at the department of Pharmacy, with focus on Pharmacokinetics of antifungals in morbidly obese adults.

Kees Kramers appointed Professor of Medication safety